SERCEB is one of eleven Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases funded by the National Institute of Allergy and Infectious Disease (NIAID) to support basic and translational research focused on emerging infections and potential bioterror agents that may threaten the health of our nation. Now in its eighth year, SERCEB is headquartered at the University of North Carolina in Chapel Hill and supports investigators at more than ten institutions across the Southeast (Region IV).
SERCEB is governed by a Steering Committee led by the Director, Dr. Fred Sparling, and Co-Director, Jenny Ting, and made up of representatives (Steering Committee) from each member institution. The decisions and actions of the Steering Committee are supported by the Evaluation and Advisory Committee (EAC) and our NIAID Program Officers.
- P. Frederick Sparling, Director, University of North Carolina
- Jenny Ting, Co-Director, University of North Carolina
- Diana McAlister, SERCEB Financial Manager, University of North Carolina
- Barb Vilen, SERCEB Program Manager, University of North Carolina
- Mark R. Denison, Vanderbilt University
- Richard W. Moyer, University of Florida
- Joseph W. St. Geme III, Duke University
- P. Frederick Sparling, University of North Carolina (ex officio)
- David S. Stephens, Emory University
- Jenny P.-Y. Ting, University of North Carolina
- Richard J. Whitley, University of Alabama at Birmingham